Humana/$HUM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Humana

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Ticker

$HUM
Sector

Primary listing

NYSE

Employees

65,680

Humana Metrics

BasicAdvanced
$33B
20.94
$13.04
0.45
$3.54
1.30%

What the Analysts think about Humana

Analyst ratings (Buy, Hold, Sell) for Humana stock.

Bulls say / Bears say

Humana raised its full-year 2025 adjusted EPS guidance to approximately $17.00 from $16.25, surpassing the analyst consensus of $16.38 and fueling a nearly 6% premarket share gain on July 30, 2025. (Reuters)
Outperformance in the CenterWell primary care unit, evidenced by stronger-than-expected patient growth and service revenue, diversified Humana’s revenue base and underpinned its Q2 earnings beat. (Reuters)
Humana’s public support for legislative efforts to curb controversial Medicare Advantage billing practices signals proactive regulatory cooperation that may reduce future compliance costs and reputational risk. (Reuters)
Despite improved retention, Humana still anticipates declines in Medicare Advantage membership in 2025, which could constrain premium revenue growth. (Reuters)
A Texas federal judge dismissed Humana’s challenge to its reduced CMS star ratings, risking lower Quality Bonus Payments and potential adverse impacts on 2026 government reimbursements. (Reuters)
Humana’s medical cost ratio remained elevated at 89.7% in Q2 2025, up from 88.9% a year ago, reflecting persistent utilization pressures that could erode margin improvements. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.

Humana Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Humana Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HUM

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Sept26
Humana
DividendEx-dividend
Oct31
Humana
DividendPayment
$0.885Per share
FAQs